Table 2

Relative survival for men and women with type 2 diabetes compared with men and women with the same age from the general population

Men							Women
Follow-up	N	Death	Lost to follow-up	COS	CES	Relative cumulative survival	N	Death	Lost to follow-up	COS	CES	Relative cumulative survival
0–1	800	36	1	0.96	0.97	0.99 (0.97–1.00)	1015	35	2	0.97	0.97	0.99 (0.98–1.00)
1–2	763	38	0	0.91	0.93	0.97 (0.95–0.99)	978	32	0	0.93	0.94	0.99 (0.97–1.00)
2–3	725	38	0	0.86	0.90	0.96 (0.93–0.98)	946	53	0	0.88	0.92	0.96 (0.94–0.98)
3–4	687	28	1	0.82	0.87	0.95 (0.92–0.98)	893	40	2	0.84	0.89	0.95 (0.92–0.97)
4–5	658	31	0	0.79	0.83	0.94 (0.91–0.98)	851	41	0	0.80	0.86	0.94 (0.91–0.96)
5–6	627	35	1	0.74	0.80	0.93 (0.89–0.96)	810	52	4	0.75	0.83	0.91 (0.88–0.94)
6–7	591	30	3	0.70	0.77	0.91 (0.87–0.95)	754	33	6	0.72	0.79	0.90 (0.87–0.94)
7–8	558	26	1	0.67	0.74	0.91 (0.86–0.95)	715	40	0	0.68	0.76	0.89 (0.85–0.92)
8–9	531	22	0	0.64	0.71	0.91 (0.86–0.95)	675	38	3	0.64	0.73	0.87 (0.83–0.91)
9–10	509	20	0	0.62	0.68	0.91 (0.86–0.96)	634	30	0	0.61	0.70	0.86 (0.82–0.91)
10–11	489	15	58	0.60	0.65	0.92 (0.86–0.97)	604	35	62	0.57	0.67	0.85 (0.80–0.89)
11–12	416	22	101	0.56	0.62	0.90 (0.85–0.96)	507	28	93	0.54	0.64	0.84 (0.79–0.88)
12–13	293	17	3	0.53	0.59	0.89 (0.83–0.95)	386	26	4	0.50	0.61	0.82 (0.77–0.88)
13–14	273	16	60	0.49	0.56	0.88 (0.81–0.94)	356	18	97	0.47	0.58	0.82 (0.76–0.87)

CES, cumulative expected survival.; COS, cumulative observed survival; N, number of patients at risk.